Skip to main content
Log in

Assessing burden of moderate-to-severe psoriasis in Brazil

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by Novartis Biociencias S.A., Brazil.

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Assessing burden of moderate-to-severe psoriasis in Brazil. PharmacoEcon Outcomes News 836, 3 (2019). https://doi.org/10.1007/s40274-019-6176-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6176-z

Navigation